271 related articles for article (PubMed ID: 15194169)
1. Autoimmunity induced by adjuvant hydrocarbon oil components of vaccine.
Kuroda Y; Nacionales DC; Akaogi J; Reeves WH; Satoh M
Biomed Pharmacother; 2004 Jun; 58(5):325-37. PubMed ID: 15194169
[TBL] [Abstract][Full Text] [Related]
2. Induction of lupus autoantibodies by adjuvants.
Satoh M; Kuroda Y; Yoshida H; Behney KM; Mizutani A; Akaogi J; Nacionales DC; Lorenson TD; Rosenbauer RJ; Reeves WH
J Autoimmun; 2003 Aug; 21(1):1-9. PubMed ID: 12892730
[TBL] [Abstract][Full Text] [Related]
3. Distinctive patterns of autoimmune response induced by different types of mineral oil.
Kuroda Y; Akaogi J; Nacionales DC; Wasdo SC; Szabo NJ; Reeves WH; Satoh M
Toxicol Sci; 2004 Apr; 78(2):222-8. PubMed ID: 14718649
[TBL] [Abstract][Full Text] [Related]
4. Induction of lupus-related specific autoantibodies by non-specific inflammation caused by an intraperitoneal injection of n-hexadecane in BALB/c mice.
Kuroda Y; Ono N; Akaogi J; Nacionales DC; Yamasaki Y; Barker TT; Reeves WH; Satoh M
Toxicology; 2006 Feb; 218(2-3):186-96. PubMed ID: 16309812
[TBL] [Abstract][Full Text] [Related]
5. Requirement of dying cells and environmental adjuvants for the induction of autoimmunity.
Bondanza A; Zimmermann VS; Dell'Antonio G; Cin ED; Balestrieri G; Tincani A; Amoura Z; Piette JC; Sabbadini MG; Rovere-Querini P; Manfredi AA
Arthritis Rheum; 2004 May; 50(5):1549-60. PubMed ID: 15146425
[TBL] [Abstract][Full Text] [Related]
6. Vaccination, squalene and anti-squalene antibodies: facts or fiction?
Lippi G; Targher G; Franchini M
Eur J Intern Med; 2010 Apr; 21(2):70-3. PubMed ID: 20206873
[TBL] [Abstract][Full Text] [Related]
7. Comparison of Montanide adjuvants, IMS 3012 (Nanoparticle), ISA 206 and ISA 35 (Emulsion based) along with incomplete Freund's adjuvant for hyperimmunization of equines used for production of polyvalent snake antivenom.
Waghmare A; Deopurkar RL; Salvi N; Khadilkar M; Kalolikar M; Gade SK
Vaccine; 2009 Feb; 27(7):1067-72. PubMed ID: 19100805
[TBL] [Abstract][Full Text] [Related]
8. [Innovation of vaccine adjuvants].
Shimizu Y; Karamatsu K; Matsubara A; Yasutomi Y
Nihon Rinsho; 2008 Oct; 66(10):1915-21. PubMed ID: 18939490
[TBL] [Abstract][Full Text] [Related]
9. Comparison of immune and adverse effects induced by AdjuVac and Freund's complete adjuvant in New Zealand white rabbits (Oryctolagus cuniculus).
Powers JG; Nash PB; Rhyan JC; Yoder CA; Miller LA
Lab Anim (NY); 2007 Oct; 36(9):51-8. PubMed ID: 17885664
[TBL] [Abstract][Full Text] [Related]
10. Pristane-induced autoimmunity in germ-free mice.
Mizutani A; Shaheen VM; Yoshida H; Akaogi J; Kuroda Y; Nacionales DC; Yamasaki Y; Hirakata M; Ono N; Reeves WH; Satoh M
Clin Immunol; 2005 Feb; 114(2):110-8. PubMed ID: 15639644
[TBL] [Abstract][Full Text] [Related]
11. Influence of hydrocarbon oil structure on adjuvanticity and autoimmunity.
Yau ACY; Lönnblom E; Zhong J; Holmdahl R
Sci Rep; 2017 Nov; 7(1):14998. PubMed ID: 29118363
[TBL] [Abstract][Full Text] [Related]
12. Oily adjuvants and autoimmunity: now time for reconsideration?
Whitehouse M
Lupus; 2012 Feb; 21(2):217-22. PubMed ID: 22235056
[TBL] [Abstract][Full Text] [Related]
13. Immunization with recombinant Brucella species outer membrane protein Omp16 or Omp19 in adjuvant induces specific CD4+ and CD8+ T cells as well as systemic and oral protection against Brucella abortus infection.
Pasquevich KA; Estein SM; García Samartino C; Zwerdling A; Coria LM; Barrionuevo P; Fossati CA; Giambartolomei GH; Cassataro J
Infect Immun; 2009 Jan; 77(1):436-45. PubMed ID: 18981242
[TBL] [Abstract][Full Text] [Related]
14. Induction of the 'ASIA' syndrome in NZB/NZWF1 mice after injection of complete Freund's adjuvant (CFA).
Bassi N; Luisetto R; Del Prete D; Ghirardello A; Ceol M; Rizzo S; Iaccarino L; Gatto M; Valente ML; Punzi L; Doria A
Lupus; 2012 Feb; 21(2):203-9. PubMed ID: 22235054
[TBL] [Abstract][Full Text] [Related]
15. Polyclonal hypergammaglobulinemia and autoantibody production induced by vaccination in farmed Atlantic salmon.
Satoh M; Bjerkås I; Haugarvoll E; Chan EK; Szabo NJ; Jirillo E; Poppe TT; Sveier H; Tørud B; Koppang EO
Fish Shellfish Immunol; 2011; 30(4-5):1080-6. PubMed ID: 21316456
[TBL] [Abstract][Full Text] [Related]
16. The non-toxic and biodegradable adjuvant Montanide ISA 720/CpG can replace Freund's in a cancer vaccine targeting ED-B--a prerequisite for clinical development.
Huijbers EJ; Femel J; Andersson K; Björkelund H; Hellman L; Olsson AK
Vaccine; 2012 Jan; 30(2):225-30. PubMed ID: 22079080
[TBL] [Abstract][Full Text] [Related]
17. Using Poly I:C as an adjuvant does not induce or exacerbate models of systemic lupus erythematosus.
Annable T; Tomassian T; Jain S; Leibbrandt M; Cooke MP; Deane JA
Autoimmunity; 2015 Feb; 48(1):29-39. PubMed ID: 25483245
[TBL] [Abstract][Full Text] [Related]
18. Bystander activation of irrelevant CD4+ T cells following antigen-specific vaccination occurs in the presence and absence of adjuvant.
van Aalst S; Ludwig IS; van der Zee R; van Eden W; Broere F
PLoS One; 2017; 12(5):e0177365. PubMed ID: 28489886
[TBL] [Abstract][Full Text] [Related]
19. Influenza vaccine with squalene adjuvant: new preparation. No better than available products.
Prescrire Int; 2004 Dec; 13(74):206-8. PubMed ID: 15599987
[TBL] [Abstract][Full Text] [Related]
20. Development of adjuvant monarthritis is critically dependent on the induction protocol: comment on the article by Busso et al.
Ferrell W; Kelso E; Lockhart J; Dunning L
Arthritis Rheum; 2007 Oct; 56(10):3510. PubMed ID: 17907181
[No Abstract] [Full Text] [Related]
[Next] [New Search]
